PC-13 35 High/Low	PC-13 Value	ProbeId	Name	Aliases	Description	Function	Protein Families	
high	12.6996373472	209619_at	CD74	CD74;DHLAG;HLADG;Ia-GAMMA	CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)	MHC class II receptor activity (GO:0045012);chaperone activity (GO:0003754);class II major histocompatibility complex antigen (GO:0003821);immune response (GO:0006955)	MHC class II-associated invariant chain, ectoplasmic trimerization (IPR008933);Thyroglobulin type-1 (IPR000716)	
high	11.5566081629	211991_s_at	HLA-DPA1	HLA-DP1A;HLA-DPA1;HLADP;HLASB	major histocompatibility complex, class II, DP alpha 1	MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);immune response (GO:0006955)	Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);MHC Class II alpha chain, alpha-1 domain (IPR001003)	
high	11.4713360193	211990_at	HLA-DPA1	HLA-DP1A;HLA-DPA1;HLADP;HLASB	major histocompatibility complex, class II, DP alpha 1	MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);immune response (GO:0006955)	Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);MHC Class II alpha chain, alpha-1 domain (IPR001003)	
high	11.3971705291	210982_s_at	HLA-DRA	HLA-DRA;HLA-DRA1	major histocompatibility complex, class II, DR alpha	MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);immune response (GO:0006955)	Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);MHC Class II alpha chain, alpha-1 domain (IPR001003)	
high	11.3470246665	212999_x_at	HLA-DQB1	CELIAC1;HLA-DQB;HLA-DQB1;IDDM1	major histocompatibility complex, class II, DQ beta 1	MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);immune response (GO:0006955)	Class II histocompatibility antigen, beta chain, beta-1 domain (IPR000353);Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
high	11.0299485228	203290_at	HLA-DQA1	CELIAC1;DQA1;HLA-DQ;HLA-DQA;HLA-DQA1	major histocompatibility complex, class II, DQ alpha 1	MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);class II major histocompatibility complex antigen (GO:0003821);immune response (GO:0006955);pathogenesis (GO:0009405)	Bipartite nuclear localization signal (IPR001472);Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);MHC Class II alpha chain, alpha-1 domain (IPR001003)	
high	10.6077828688	212998_x_at	HLA-DQB1	CELIAC1;HLA-DQB;HLA-DQB1;IDDM1	major histocompatibility complex, class II, DQ beta 1	MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);immune response (GO:0006955)	Class II histocompatibility antigen, beta chain, beta-1 domain (IPR000353);Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
high	10.3447628056	212671_s_at	HLA-DQA2	HLA-DQA2;HLA-DXA	major histocompatibility complex, class II, DQ alpha 2	MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);immune response (GO:0006955)	Bipartite nuclear localization signal (IPR001472);Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);MHC Class II alpha chain, alpha-1 domain (IPR001003)	
high	10.29508504	208894_at	HLA-DRA	HLA-DRA;HLA-DRA1	major histocompatibility complex, class II, DR alpha	MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);immune response (GO:0006955)	Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);MHC Class II alpha chain, alpha-1 domain (IPR001003)	
high	10.1787683112	gnf1h09726_s_at	gnf1h09726_s_at	None	None	None	None	
high	10.0942768956	216834_at	RGS1	1R20;BL34;IER1;IR20;RGS1	regulator of G-protein signalling 1	B-cell activation (GO:0042113);G-protein signaling\, adenylate cyclase inhibiting pathway (GO:0007193);GTPase activator activity (GO:0005096);calmodulin binding (GO:0005516);immune response (GO:0006955);signal transducer activity (GO:0004871);signal transduction (GO:0007165)	Regulator of G protein (IPR000342)	
high	9.79030253014	204670_x_at	HLA-DRB3	HLA-DR1B;HLA-DR3B;HLA-DR4B;HLA-DRB1;HLA-DRB3;HLA-DRB4;HLA-DRB5	major histocompatibility complex, class II, DR beta 3	MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);class II major histocompatibility complex antigen (GO:0003821);immune response (GO:0006955);pathogenesis (GO:0009405);signal transduction (GO:0007165)	Class II histocompatibility antigen, beta chain, beta-1 domain (IPR000353);Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
high	9.66366340198	209312_x_at	HLA-DRB3	HLA-DR1B;HLA-DR3B;HLA-DR4B;HLA-DRB1;HLA-DRB3;HLA-DRB4;HLA-DRB5	major histocompatibility complex, class II, DR beta 3	MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);class II major histocompatibility complex antigen (GO:0003821);immune response (GO:0006955);pathogenesis (GO:0009405);signal transduction (GO:0007165)	Class II histocompatibility antigen, beta chain, beta-1 domain (IPR000353);Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
high	9.61813059688	208306_x_at	HLA-DRB3	HLA-DR1B;HLA-DR3B;HLA-DR4B;HLA-DRB1;HLA-DRB3;HLA-DRB4;HLA-DRB5	major histocompatibility complex, class II, DR beta 3	MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);class II major histocompatibility complex antigen (GO:0003821);immune response (GO:0006955);pathogenesis (GO:0009405);signal transduction (GO:0007165)	Class II histocompatibility antigen, beta chain, beta-1 domain (IPR000353);Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
high	9.60906552037	204430_s_at	SLC2A5	GLUT5;SLC2A5	solute carrier family 2 (facilitated glucose/fructose transporter), member 5	carbohydrate metabolism (GO:0005975);carbohydrate transport (GO:0008643);fructose transport (GO:0015755);fructose transporter activity (GO:0005353);glucose transport (GO:0015758);glucose transporter activity (GO:0005355);sugar porter activity (GO:0005351);transport (GO:0006810);transporter activity (GO:0005215)	Beta and gamma crystallin (IPR001064);Fructose transporter (GLUT5) (IPR002442);General substrate transporter (IPR005828);Major facilitator superfamily (IPR007114);Sugar transporter (IPR003663);Sugar transporter superfamily (IPR005829)	
high	9.60383742176	201560_at	CLIC4	CLIC4;CLIC4L;DKFZP566G223;P64H1;huH1;p64H1	chloride intracellular channel 4	chloride channel activity (GO:0005254);chloride transport (GO:0006821);ion transport (GO:0006811);voltage-gated chloride channel activity (GO:0005247)	Glutathione S-transferase, C-terminal (IPR004046);Intracellular chloride channel (IPR002946)	
high	9.58105091583	215193_x_at	HLA-DRB3	HLA-DR1B;HLA-DR3B;HLA-DR4B;HLA-DRB1;HLA-DRB3;HLA-DRB4;HLA-DRB5	major histocompatibility complex, class II, DR beta 3	MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);class II major histocompatibility complex antigen (GO:0003821);immune response (GO:0006955);pathogenesis (GO:0009405);signal transduction (GO:0007165)	Class II histocompatibility antigen, beta chain, beta-1 domain (IPR000353);Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
high	9.39658857616	209823_x_at	HLA-DQB1	CELIAC1;HLA-DQB;HLA-DQB1;IDDM1	major histocompatibility complex, class II, DQ beta 1	MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);immune response (GO:0006955)	Class II histocompatibility antigen, beta chain, beta-1 domain (IPR000353);Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
high	9.3214201173	217853_at	TENS1	FLJ13732;H_NH049I23.2;TEM6;TENS1	tensin-like SH2 domain containing 1	intracellular signaling cascade (GO:0007242);phosphoprotein phosphatase activity (GO:0004721);protein amino acid dephosphorylation (GO:0006470);protein tyrosine phosphatase activity (GO:0004725)	C2 calcium/lipid-binding domain, CaLB (IPR008973);Phosphotyrosine interaction domain (IPR006020);SH2 motif (IPR000980);Surface protein from Gram-positive cocci, anchor region (IPR001899);Tyrosine specific protein phosphatase and dual specificity protein phosphatase (IPR000387)	
high	9.00634868784	205267_at	POU2AF1	BOB1;OBF-1;OBF1;OCAB;POU2AF1	POU domain, class 2, associating factor 1	cell growth and/or maintenance (GO:0008151);humoral immune response (GO:0006959);transcription activating factor (GO:0003710);transcription coactivator activity (GO:0003713);transcription cofactor activity (GO:0003712);transcription from Pol II promoter (GO:0006366)	Proline-rich region (IPR000694)	
high	8.94968091954	204961_s_at	NCF1	NCF1;NOXO2;p47phox	neutrophil cytosolic factor 1 (47kDa, chronic granulomatous disease, autosomal 1)	GTP binding (GO:0005525);GTPase activity (GO:0003924);cellular defense response (GO:0006968);electron transport (GO:0006118);electron transporter activity (GO:0005489);intracellular signaling cascade (GO:0007242);oxygen and reactive oxygen species metabolism (GO:0006800);protein binding (GO:0005515);superoxide metabolism (GO:0006801)	Neutrophil cytosol factor 1 (IPR001655);Phox-like (IPR001683);SH3 (IPR001452)	
high	8.70169004367	204581_at	CD22	CD22;SIGLEC-2	CD22 antigen	antimicrobial humoral response (sensu Protostomia) (GO:0006960);antimicrobial humoral response (sensu Vertebrata) (GO:0019735);cell adhesion (GO:0007155);cell adhesion molecule activity (GO:0005194);heterophilic cell adhesion (GO:0007157);immune response (GO:0006955);lectin (GO:0005530);protein binding (GO:0005515);sugar binding (GO:0005529)	Immunoglobulin C-2 type (IPR003598);Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
high	8.5839276117	210258_at	RGS13	MGC17173;RGS13	regulator of G-protein signalling 13	signal transducer activity (GO:0004871);signal transduction (GO:0007165)	Regulator of G protein (IPR000342)	
high	8.57326081564	207655_s_at	BLNK	BLNK;BLNK-s;Ly57;SLP-65;SLP65	B-cell linker	B-cell differentiation (GO:0030183);SH3/SH2 adaptor protein activity (GO:0005070);hemocyte development (GO:0007516);humoral immune response (GO:0006959);inflammatory response (GO:0006954);intracellular signaling cascade (GO:0007242);transmembrane receptor protein tyrosine kinase adaptor protein activity (GO:0005068)	Proline-rich region (IPR000694);SH2 motif (IPR000980)	
high	8.43016135877	209200_at	MEF2C	MEF2C	MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)	RNA polymerase II transcription factor activity (GO:0003702);muscle development (GO:0007517);neurogenesis (GO:0007399);transcription (GO:0006350);transcription coactivator activity (GO:0003713);transcription factor activity (GO:0003700);transcription from Pol II promoter (GO:0006366);translation regulator activity (GO:0045182)	Transcription factor, MADS-box (IPR002100)	
high	8.22748316648	211430_s_at	IGHG1	IGHG1	immunoglobulin heavy constant gamma 1 (G1m marker)	antigen binding (GO:0003823);immune response (GO:0006955)	Immunoglobulin C-type (IPR003597);Immunoglobulin V-type (IPR003596);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
high	8.19557385482	217478_s_at	HLA-DMA	D6S222E;HLA-DMA;HLADM;RING6	major histocompatibility complex, class II, DM alpha	MHC class II receptor activity (GO:0045012);MHC-interacting protein (GO:0003822);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);chaperone activity (GO:0003754);immune response (GO:0006955);protein binding (GO:0005515)	Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006);MHC Class II alpha chain, alpha-1 domain (IPR001003)	
high	8.02807770131	203571_s_at	C10orf116	APM2;C10orf116	chromosome 10 open reading frame 116	biological_process unknown (GO:0000004);molecular_function unknown (GO:0005554)	None	
high	8.02510091805	201422_at	IFI30	GILT;IFI-30;IFI30;IP30;MGC32056	interferon, gamma-inducible protein 30	immune response (GO:0006955);oxidoreductase activity (GO:0016491)	Gamma interferon inducible lysosomal thiol reductase GILT (IPR004911)	
high	7.97957378523	207540_s_at	SYK	SYK	spleen tyrosine kinase	ATP binding (GO:0005524);cell proliferation (GO:0008283);histogenesis and organogenesis (GO:0007397);integrin binding (GO:0005178);integrin-mediated signaling pathway (GO:0007229);intracellular signaling cascade (GO:0007242);leukocyte cell adhesion (GO:0007159);neutrophil chemotaxis (GO:0030593);organogenesis (GO:0009887);protein amino acid phosphorylation (GO:0006468);protein complex assembly (GO:0006461);protein-tyrosine kinase activity (GO:0004713);transferase activity (GO:0016740)	Protein kinase (IPR000719);SH2 motif (IPR000980);Serine/threonine protein kinase (IPR002290);Tyrosine protein kinase (IPR001245)	
high	7.92043025793	211656_x_at	HLA-DQB1	CELIAC1;HLA-DQB;HLA-DQB1;IDDM1	major histocompatibility complex, class II, DQ beta 1	MHC class II receptor activity (GO:0045012);antigen presentation, exogenous antigen (GO:0019884);antigen processing, exogenous antigen via MHC class II (GO:0019886);immune response (GO:0006955)	Class II histocompatibility antigen, beta chain, beta-1 domain (IPR000353);Immunoglobulin C-type (IPR003597);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
high	7.8472969394	209170_s_at	GPM6B	GPM6B;M6B	glycoprotein M6B	molecular_function unknown (GO:0005554);neurogenesis (GO:0007399)	Myelin proteolipid protein PLP (IPR001614)	
high	7.83474273758	202284_s_at	CDKN1A	CAP20;CDKN1;CDKN1A;CIP1;MDA-6;P21;SDI1;WAF1	cyclin-dependent kinase inhibitor 1A (p21, Cip1)	cell cycle regulator (GO:0003750);cyclin-dependent protein kinase inhibitor activity (GO:0004861);kinase activity (GO:0016301);negative regulation of cell proliferation (GO:0008285);oncogenesis (GO:0007048);protein kinase activity (GO:0004672);regulation of cyclin dependent protein kinase activity (GO:0000079);tumor suppressor (GO:0008181)	Bipartite nuclear localization signal (IPR001472);Cyclin-dependent kinase inhibitor (IPR003175)	
high	7.79437417748	217422_s_at	CD22	CD22;SIGLEC-2	CD22 antigen	antimicrobial humoral response (sensu Protostomia) (GO:0006960);antimicrobial humoral response (sensu Vertebrata) (GO:0019735);cell adhesion (GO:0007155);cell adhesion molecule activity (GO:0005194);heterophilic cell adhesion (GO:0007157);immune response (GO:0006955);lectin (GO:0005530);protein binding (GO:0005515);sugar binding (GO:0005529)	Immunoglobulin C-2 type (IPR003598);Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
high	7.74035375028	gnf1h04624_at	gnf1h04624_at	None	None	None	None	
low	-7.01548053785	205270_s_at	LCP2	LCP2;SLP-76;SLP76	lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)	immune response (GO:0006955);intracellular signaling cascade (GO:0007242);protein binding (GO:0005515);transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	Proline-rich region (IPR000694);SH2 motif (IPR000980);Sterile alpha motif SAM (IPR001660)	
low	-7.07593019227	215262_at	Hs.142570	None	Clone 24629 mRNA sequence	None	None	
low	-7.10603071732	208322_s_at	SIAT4A	Gal-NAc6S;MGC9183;SIAT4A;SIATFL;ST3GalA.1;ST3GalIA;ST3O	sialyltransferase 4A (beta-galactoside alpha-2,3-sialyltransferase)	beta-galactoside alpha-2,3-sialyltransferase activity (GO:0003836);protein amino acid glycosylation (GO:0006486);protein modification (GO:0006464);transferase activity, transferring glycosyl groups (GO:0016757)	Glycosyl transferase, family 29 (IPR001675)	
low	-7.13800419405	209871_s_at	APBA2	APBA2;D15S1518E;HsT16821;LIN-10;MGC:14091;MINT2;X11L	amyloid beta (A4) precursor protein-binding, family A, member 2 (X11-like)	amyloid protein (GO:0005208);intracellular protein transport (GO:0006886);neurogenesis (GO:0007399);pathogenesis (GO:0009405);protein binding (GO:0005515);protein transporter activity (GO:0008565)	PDZ/DHR/GLGF domain (IPR001478);Phosphotyrosine interaction domain (IPR006020)	
low	-7.14412796923	210847_x_at	TNFRSF25	APO-3;DDR3;DR3;LARD;TNFRSF12;TNFRSF25;TR3;TRAMP;WSL-1;WSL-LR	tumor necrosis factor receptor superfamily, member 25	NGF/TNF (6 C-domain) receptor activity (GO:0005027);apoptosis (GO:0006915);apoptosis regulator activity (GO:0016329);cell surface receptor linked signal transduction (GO:0007166);molecular_function unknown (GO:0005554);receptor activity (GO:0004872);signal transduction (GO:0007165);tumor necrosis factor receptor activity (GO:0005031)	Death domain (IPR000488);TNFR/CD27/30/40/95 cysteine-rich region (IPR001368)	
low	-7.16082407934	210606_x_at	KLRD1	CD94;KLRD1	killer cell lectin-like receptor subfamily D, member 1	antimicrobial humoral response (sensu Protostomia) (GO:0006960);antimicrobial humoral response (sensu Vertebrata) (GO:0019735);cell surface receptor linked signal transduction (GO:0007166);heterophilic cell adhesion (GO:0007157);lectin (GO:0005530);receptor activity (GO:0004872);sugar binding (GO:0005529);transmembrane receptor activity (GO:0004888)	C-type lectin (IPR001304);EGF-like domain (IPR006209)	
low	-7.20215491178	gnf1h07020_s_at	gnf1h07020_s_at	None	None	None	Immunoglobulin V-type (IPR003596);Immunoglobulin/major histocompatibility complex (IPR003006)	
low	-7.22109302973	210031_at	CD3Z	CD3-ZETA;CD3H;CD3Q;CD3Z;TCRZ	CD3Z antigen, zeta polypeptide (TiT3 complex)	T-cell receptor activity (GO:0004894);cell surface receptor linked signal transduction (GO:0007166);cellular defense response (GO:0006968);protein binding (GO:0005515);protein homodimerization activity (GO:0042803);receptor signaling protein activity (GO:0005057);transmembrane receptor activity (GO:0004888)	Bipartite nuclear localization signal (IPR001472)	
low	-7.25730983739	206666_at	GZMK	GZMK;PRSS;TRYP2	granzyme K (serine protease, granzyme 3; tryptase II)	chymotrypsin activity (GO:0004263);hydrolase activity (GO:0016787);proteolysis and peptidolysis (GO:0006508);serine-type peptidase activity (GO:0008236);trypsin activity (GO:0004295)	Peptidase S1, chymotrypsin (IPR001254);Peptidase S1A, chymotrypsin (IPR001314);Peptidase, trypsin-like serine and cysteine proteases (IPR009003)	
low	-7.36846276054	205495_s_at	GNLY	519;D2S69E;GNLY;LAG-2;LAG2;NKG5;TLA519	granulysin	antibacterial peptide activity (GO:0003797);antifungal peptide activity (GO:0003799);cellular defense response (GO:0006968);defense response to fungi (GO:0050832);xenobiotic metabolism (GO:0006805)	Saposin B (IPR008139);Saposin-like type B, 2 (IPR008138)	
low	-7.38025687541	205798_at	IL7R	CD127;CDW127;IL-7R-alpha;IL7R	interleukin 7 receptor	antigen binding (GO:0003823);antimicrobial humoral response (sensu Protostomia) (GO:0006960);antimicrobial humoral response (sensu Vertebrata) (GO:0019735);cell surface receptor linked signal transduction (GO:0007166);hematopoietin/interferon-class (D200-domain) cytokine receptor activity (GO:0004896);immune response (GO:0006955);interleukin-7 receptor activity (GO:0004917);receptor activity (GO:0004872);signal transduction (GO:0007165)	Fibronectin, type III (IPR003961);Fibronectin, type III-like fold (IPR008957);Short hematopoietin receptor, family 1 (IPR003531)	
low	-7.3915288865	210321_at	GZMH	CCP-X;CGL-2;CSP-C;CTLA1;CTSGL2;GZMH	granzyme H (cathepsin G-like 2, protein h-CCPX)	apoptosis (GO:0006915);chymotrypsin activity (GO:0004263);cytolysis (GO:0019835);hydrolase activity (GO:0016787);proteolysis and peptidolysis (GO:0006508);serine-type endopeptidase activity (GO:0004252);trypsin activity (GO:0004295)	Peptidase S1, chymotrypsin (IPR001254);Peptidase S1A, chymotrypsin (IPR001314);Peptidase, trypsin-like serine and cysteine proteases (IPR009003)	
low	-7.39824780424	211144_x_at	TRG@	TCRG;TRG;TRG@	T cell receptor gamma locus	immune response (GO:0006955);transmembrane receptor activity (GO:0004888)	None	
low	-7.50344965654	206804_at	CD3G	CD3-GAMMA;CD3G;T3G	CD3G antigen, gamma polypeptide (TiT3 complex)	T-cell activation (GO:0042110);T-cell receptor activity (GO:0004894);T-cell receptor binding (GO:0042608);cell surface receptor linked signal transduction (GO:0007166);cellular defense response (GO:0006968);development (GO:0007275);establishment and/or maintenance of cell polarity (GO:0007163);protein complex assembly (GO:0006461);protein heterodimerization activity (GO:0046982);protein transport (GO:0015031);receptor signaling complex scaffold activity (GO:0030159);receptor signaling protein activity (GO:0005057);thymocyte differentiation (GO:0046652);transmembrane receptor activity (GO:0004888)	Immunoglobulin C-2 type (IPR003598);Immunoglobulin-like (IPR007110)	
low	-7.52246219814	210915_x_at	M15564	None	None	None	None	
low	-7.58742230506	215236_s_at	PICALM	CALM;CLTH;LAP;PICALM	phosphatidylinositol binding clathrin assembly protein	cell growth and/or maintenance (GO:0008151);clathrin binding (GO:0030276);phosphatidylinositol binding (GO:0005545);protein complex assembly (GO:0006461);receptor mediated endocytosis (GO:0006898);vesicle-mediated transport (GO:0016192)	Epsin N-terminal homology (IPR001026);Phosphoinositide-binding clathrin adaptor, N-terminal (IPR008943)	
low	-7.59338062872	205488_at	GZMA	CTLA3;GZMA;HFSP	granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)	apoptosis (GO:0006915);chymotrypsin activity (GO:0004263);cytolysis (GO:0019835);granzyme A activity (GO:0004277);hydrolase activity (GO:0016787);immune response (GO:0006955);proteolysis and peptidolysis (GO:0006508);trypsin activity (GO:0004295)	Peptidase S1, chymotrypsin (IPR001254);Peptidase S1A, chymotrypsin (IPR001314);Peptidase, trypsin-like serine and cysteine proteases (IPR009003)	
low	-7.63515140483	209278_s_at	TFPI2	PP5;TFPI-2;TFPI2	tissue factor pathway inhibitor 2	blood coagulation (GO:0007596);extracellular matrix glycoprotein (GO:0005207);extracellular matrix structural constituent (GO:0005201);protease inhibitor activity (GO:0030414);serine-type endopeptidase inhibitor activity (GO:0004867)	Protease inhibitor I2, Kunitz metazoa (IPR002223);Tissue factor pathway inhibitor (IPR008296)	
low	-7.69409546281	207651_at	H963	H963	platelet activating receptor homolog	G-protein coupled receptor activity (GO:0004930);G-protein coupled receptor protein signaling pathway (GO:0007186);purinergic nucleotide receptor activity\, G-protein coupled (GO:0045028);receptor activity (GO:0004872);rhodopsin-like receptor activity (GO:0001584)	Rhodopsin-like GPCR superfamily (IPR000276)	
low	-7.77525450216	216191_s_at	TRD@	TCRD;TRD;TRD@	T cell receptor delta locus	None	None	
low	-7.78023729858	211821_x_at	GYPA	GPA;GYPA;MNS	glycophorin A (includes MN blood group)	biological_process unknown (GO:0000004);blood group antigen (GO:0005555);invasive growth (GO:0007125);molecular_function unknown (GO:0005554)	Glycophorin A and B (IPR001195)	
low	-7.82726908702	210948_s_at	LEF1	LEF1;TCF1ALPHA	lymphoid enhancer-binding factor 1	DNA binding (GO:0003677);Wnt receptor signaling pathway (GO:0016055)	HMG1/2 (high mobility group) box (IPR000910);Proline-rich region (IPR000694)	
low	-7.86817852232	213915_at	NKG7	GIG1;NKG7	natural killer cell group 7 sequence	None	PMP-22/EMP/MP20 (IPR004032);PMP-22/EMP/MP20 and claudin (IPR004031)	
low	-7.93584070551	gnf1h07051_s_at	gnf1h07051_s_at	None	None	None	Immunoglobulin V-type (IPR003596);Immunoglobulin/major histocompatibility complex (IPR003006)	
low	-8.01037639437	214470_at	KLRB1	CD161;KLRB1;NKR;NKR-P1;NKR-P1A;NKRP1A	killer cell lectin-like receptor subfamily B, member 1	antimicrobial humoral response (sensu Protostomia) (GO:0006960);antimicrobial humoral response (sensu Vertebrata) (GO:0019735);cell surface receptor linked signal transduction (GO:0007166);lectin (GO:0005530);sugar binding (GO:0005529);transmembrane receptor activity (GO:0004888)	C-type lectin (IPR001304)	
low	-8.021521565	211796_s_at	211796_s_at	None	None	None	Immunoglobulin C-type (IPR003597);Immunoglobulin/major histocompatibility complex (IPR003006)	
low	-8.08490863562	205758_at	CD8A	CD8;CD8A;Leu2;MAL;p32	CD8 antigen, alpha polypeptide (p32)	MHC class I protein binding (GO:0042288);T-cell activation (GO:0042110);T-cell receptor activity (GO:0004894);antigen presentation (GO:0019882);cellular defense response (sensu Vertebrata) (GO:0016066);coreceptor activity (GO:0015026);immune response (GO:0006955);protein binding (GO:0005515);transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	Immunoglobulin V-type (IPR003596);Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
low	-8.11105664032	214450_at	CTSW	CTSW;LYPN	cathepsin W (lymphopain)	cysteine-type endopeptidase activity (GO:0004197);cysteine-type peptidase activity (GO:0008234);hydrolase activity (GO:0016787);immune response (GO:0006955);proteolysis and peptidolysis (GO:0006508)	Peptidase C1A, papain (IPR000668);Peptidase, eukaryotic cysteine peptidase active site (IPR000169)	
low	-8.19762449973	217143_s_at	TRD@	TCRD;TRD;TRD@	T cell receptor delta locus	None	None	
low	-8.374638606	213539_at	CD3D	CD3-DELTA;CD3D;T3D	CD3D antigen, delta polypeptide (TiT3 complex)	T-cell activation (GO:0042110);cell surface receptor linked signal transduction (GO:0007166);positive thymic T-cell selection (GO:0045059);protein binding (GO:0005515);protein complex assembly (GO:0006461);protein heterodimerization activity (GO:0046982);transmembrane receptor activity (GO:0004888)	None	
low	-8.80699068492	209813_x_at	TRGV9	TCRGV9;TRGV9	T cell receptor gamma variable 9	MHC protein binding (GO:0042287);cellular defense response (sensu Vertebrata) (GO:0016066);peptide antigen binding (GO:0042605)	None	
low	-9.03915056557	214551_s_at	CD7	CD7;GP40;LEU-9;TP41;Tp40	CD7 antigen (p41)	T-cell activation (GO:0042110);calcium ion transport (GO:0006816);cellular defense response (GO:0006968);immune response (GO:0006955);lymphocyte antigen (GO:0005557);receptor activity (GO:0004872);transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	Immunoglobulin V-type (IPR003596);Immunoglobulin subtype (IPR003599);Immunoglobulin-like (IPR007110);Immunoglobulin/major histocompatibility complex (IPR003006)	
low	-9.25386688872	204475_at	MMP1	CLG;CLGN;MMP1	matrix metalloproteinase 1 (interstitial collagenase)	calcium ion binding (GO:0005509);collagen catabolism (GO:0030574);collagenase activity (GO:0008133);hydrolase activity (GO:0016787);interstitial collagenase activity (GO:0004232);proteolysis and peptidolysis (GO:0006508);zinc ion binding (GO:0008270)	Hemopexin (IPR000585);Peptidase M10A and M12B, matrixin and adamalysin (IPR001818);Peptidase,  metallopeptidases (IPR006026)	
low	-9.31781104578	37145_at	GNLY	519;D2S69E;GNLY;LAG-2;LAG2;NKG5;TLA519	granulysin	antibacterial peptide activity (GO:0003797);antifungal peptide activity (GO:0003799);cellular defense response (GO:0006968);defense response to fungi (GO:0050832);xenobiotic metabolism (GO:0006805)	Saposin B (IPR008139);Saposin-like type B, 2 (IPR008138)	
low	-10.3784557625	203828_s_at	NK4	NK4	natural killer cell transcript 4	cell adhesion (GO:0007155);cell adhesion molecule activity (GO:0005194);defense response (GO:0006952);immune response (GO:0006955)	None